Korean J Pediatr Hematol Oncol.  2003 Oct;10(2):299-304.

Fatal Bronchiolitis Obliterans with Very Severe Subcutaneous Emphysema and Pneumomediastinum after Unrelated BMT

Affiliations
  • 1Blood & Marrow Transplantation Program, Department of Pediatrics, Chonnam National University Medical School, Gwangju, Korea. hoonkook@chonnam.ac.kr

Abstract

Bronchiolitis obliterans (BO) is a particularly severe complication that occurs in 10% to 15 % of the patients with extensive graft-versus-host disease (GVHD) and is often refractory to treatment. We report herewith a child with chronic GVHD and BO after unrelated BMT. A 8 year-old girl with Ph ALL (Philadelphia-chromosome positive acute lymphoblastic leukemia) underwent an unrelated BMT in the first complete remission. Engraftment was uneventful. Acute GVHD of the skin developed, and was treated with methylprednisolone. No evidence of GVHD flare was documented, and immunosuppression was tapered off by 7 months posttransplant. On 9 months posttransplant, chronic GVHD involving skin, liver, mouth, eyes, gastrointestinal tract, and lungs developed. Despite conservative managements, the patient developed pneumomediastinum and subcutaneous emphysema secondary to severe BO. Her condition continued to deteriorate, and she died of respiratory failure 10 months after transplant. Further studies are required to identify risk factors and to develop newer methods of effective treatment for this rare complication.

Keyword

Ph ALL; Bone marrow transplantation; Graft-versus-host disease; Bronchiolitis obliterans; Pnemomediastinum; Subcutaneous emphysema

MeSH Terms

Bone Marrow Transplantation
Bronchiolitis Obliterans*
Bronchiolitis*
Child
Female
Gastrointestinal Tract
Graft vs Host Disease
Humans
Hydrogen-Ion Concentration
Immunosuppression
Liver
Lung
Mediastinal Emphysema*
Methylprednisolone
Mouth
Respiratory Insufficiency
Risk Factors
Skin
Subcutaneous Emphysema*
Methylprednisolone
Full Text Links
  • KJPHO
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr